Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07TJT
|
|||
| Former ID |
DIB008357
|
|||
| Drug Name |
Imilecleucel-T
|
|||
| Indication | Multiple sclerosis [ICD-11: 8A40; ICD-9: 340] | Phase 2 | [1] | |
| Company |
Opexa therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01684761) Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.